Compare PVLA & HUYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PVLA | HUYA |
|---|---|---|
| Founded | 2015 | 2014 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 989.7M |
| IPO Year | N/A | 2018 |
| Metric | PVLA | HUYA |
|---|---|---|
| Price | $82.38 | $4.64 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 17 | 1 |
| Target Price | ★ $145.24 | $3.50 |
| AVG Volume (30 Days) | 243.4K | ★ 3.4M |
| Earning Date | 11-11-2025 | 03-17-2026 |
| Dividend Yield | N/A | ★ 53.43% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $879,277,448.00 |
| Revenue This Year | N/A | $9.05 |
| Revenue Next Year | N/A | $11.33 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 2.40 |
| 52 Week Low | $14.60 | $2.21 |
| 52 Week High | $114.69 | $4.69 |
| Indicator | PVLA | HUYA |
|---|---|---|
| Relative Strength Index (RSI) | 41.52 | 72.47 |
| Support Level | $74.40 | $4.20 |
| Resistance Level | $83.47 | $4.64 |
| Average True Range (ATR) | 5.91 | 0.33 |
| MACD | -1.09 | 0.05 |
| Stochastic Oscillator | 27.30 | 96.08 |
Palvella Therapeutics Inc is a late clinical-stage biopharmaceutical company committed to serving individuals suffering from serious, rare genetic skin diseases without approved therapies. The Company's lead product candidate, QTORIN 3.9 percent rapamycin anhydrous gel (QTORIN rapamycin), is based on the Company's patented QTORIN platform. QTORIN rapamycin is in clinical development for two rare genetic skin disorders.
Huya, officially became independent in 2016 and headquartered in Guangzhou, operates live streaming platform focused on games, esports, and interactive entertainment, and also provides game-related services such as distribution and in-game item sales. Its main livestreaming platforms include Huya Live in China and Nimo TV outside of China. As of 2024, Huya was a subsidiary of Tencent, which owned 67% of its equity stake and held 95% of the voting power.